Search Results - Arter ZL

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    Spotlight on Patritumab Deruxtecan (HER3-DXd) from HERTHENA Lung01. Is a Median PFS of 5.5 Months Enough in Light of FLAURA-2 and MARIPOSA? by Arter ZL, Nagasaka M

    Published in Lung Cancer: Targets and Therapy (2024-07-01)
    Get full text
    Article


  2. 2

    Adagrasib in KRYSTAL-12 has Broken the KRASG12C Enigma Code in Non-Small Cell Lung Carcinoma by Luo FX, Arter ZL

    Published in Lung Cancer: Targets and Therapy (2024-10-01)
    Get full text
    Article


  3. 3

    Redefining Recovery: The Transformative Impact of the ALINA Trial on Adjuvant Therapy for ALK-Positive Non-Small Cell Lung Cancer by Arter ZL, Nagasaka M

    Published in Lung Cancer: Targets and Therapy (2024-08-01)
    Get full text
    Article


  4. 4

    The Nail in the Coffin?: Examining the KEYNOTE-789 Clinical Trial’s Impact by Arter ZL, Nagasaka M

    Published in Lung Cancer: Targets and Therapy (2024-01-01)
    Get full text
    Article


  5. 5

    Successful and On-going Long-Term Disease Control (>24 Months) with Gilteritinib in an ALK+ NSCLC Patient with Brain Metastasis Who Has Progressed on Multiple ALK TKIs. A Ca... by Ou SHI, Park CJ, Arter ZL, Nagasaka M

    Published in Lung Cancer: Targets and Therapy (2025-10-01)
    Get full text
    Article


  6. 6

    Comprehensive Survey of AACR GENIE Database of Tumor Mutation Burden (TMB) Among All Three Classes (I, II, III) of BRAF Mutated (BRAF+) NSCLC by Arter ZL, Shieh K, Nagasaka M, Ou SHI

    Published in Lung Cancer: Targets and Therapy (2025-02-01)
    Get full text
    Article


Search Tools: